Institute of Chronic Disease Risks Assessment, Henan University, Jinming Avenue, Kaifeng 475004, China.
School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
Int J Mol Sci. 2022 Jun 15;23(12):6665. doi: 10.3390/ijms23126665.
Eva-1 homolog A (EVA1A), also known as transmembrane protein 166 (TMEM166) and regulator of programmed cell death, is an endoplasmic reticulum associated protein, which can play an important role in many diseases, including a variety of cancers, by regulating autophagy/apoptosis. However, the related mechanism, especially the role of EVA1A in cancers, has not been fully understood. In this review, we summarize the recent studies on the role of EVA1A in different types of cancers, including breast cancer, papillary thyroid cancer, non-small cell lung cancer, hepatocellular carcinoma, glioblastoma and pancreatic cancer, and analyze the relevant mechanisms to provide a theoretical basis for future related research.
Eva-1 同源物 A(EVA1A),也称为跨膜蛋白 166(TMEM166)和程序性细胞死亡调节剂,是一种内质网相关蛋白,通过调节自噬/细胞凋亡,在许多疾病中发挥重要作用,包括各种癌症。然而,相关机制,特别是 EVA1A 在癌症中的作用,尚未完全阐明。在这篇综述中,我们总结了 EVA1A 在不同类型癌症(包括乳腺癌、甲状腺乳头状癌、非小细胞肺癌、肝癌、胶质母细胞瘤和胰腺癌)中的作用的最新研究,并分析了相关机制,为未来的相关研究提供理论基础。